Pre-endoscopic intravenous proton pump inhibitors for emergency department patients with upper gastrointestinal bleeds a review of clinical effectiveness, cost-effectiveness, and guidelines
The purpose of this report is to review the clinical efficacy of pre-endoscopic intravenous proton pump inhibitors (PPI) for patients with upper gastrointestinal bleeding (UGIB) and to review the evidence-based guidelines regarding the use of proton pump inhibitors before endoscopy in patients with...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, February 5, 2016
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this report is to review the clinical efficacy of pre-endoscopic intravenous proton pump inhibitors (PPI) for patients with upper gastrointestinal bleeding (UGIB) and to review the evidence-based guidelines regarding the use of proton pump inhibitors before endoscopy in patients with UGIB. |
|---|---|
| Item Description: | "CADTH rapid response service." |
| Physical Description: | 1 PDF file (26 pages) illustrations |